Astrana Health Inc (ASTH) - Company Projected Revenue

Brandmark of Astrana Health (ASTH)

Astrana Health, Inc. (ASTH) generates revenue through contracts with US insurers and Medicare government programs based on a value-based care model. Medical services are delivered via an extensive network of centers with a streamlined supply chain for consumables. The company's sales forecast demonstrates the effectiveness of digital cost controls and management expertise, while the value of 6.78 serves as the current indicator for this metric.

ASTH - Astrana Health, Inc. Projected Sales Volume over the range 07/04/2022 - 11/15/2026

Analytical breakdowns for Astrana Health, Inc.

- current price and projected stock value:
Fundamental valuation:Astrana Health
Brand item of Astrana Corp

The implementation of digital health records and energy-efficient technologies across Astrana Health, Inc. (ASTH) centers directly impacts operational resilience and future cash flow. By analyzing the company's product delivery dynamics, investors assess projected demand and the actual commercial health of the business, where a downward trend signals an exit of institutional capital from the asset even before the publication of official financial reports.

Direct competitors

Company Future Sales Volume HCA (HCA Inc.)|THC - Company Expected Sales Volume|Projected Sales Volume FMS (freseniusmedicalcare.com)|Solventum Inc. - Company Projected Revenue|EHC - Company Projected Revenue|Company Future Revenue UHS (Universal Health Services, Inc.)|DVA (DaVita) - Company Future Sales Volume|RDNT: Company Projected Revenue Volume|Company Future Sales Volume OPCH|Company Expected Sales Volume Surgery Partners, Inc. SGRY|Company Future Sales Volume PINC (Premier, Inc.)|EYE (National Vision) - Company Future Revenue|Projected Sales Volume PGNY (Progyny Inc)|Ardent Health Partners (ARDT) - Company Expected Sales Volume|Select Medical Inc. - Projected Sales Volume|Company Expected Sales Volume Pediatrix Medical Group, Inc.|USPH: Projected Sales Volume|PNTG: Company Projected Revenue Volume|ORGO (Organogenesis Holdings Inc.) - Projected Sales Volume|NUTX: Company Future Revenue|Company Projected Revenue Auna Health (AUNA)|SBC (SBC Medical Group Holdings) - Company Future Revenue|Company Projected Revenue Evolus, Inc. EOLS|Company Projected Revenue Volume CYH (Community Health Systems)|SKIN - Company Projected Revenue|mediwound.com (MDWD) - Company Future Sales Volume|BTMD (biote Corp) - Company Future Sales Volume|JYNT: Company Projected Revenue Volume|DCGO (DocGo, Inc.) - Projected Sales Volume|Company Projected Revenue PIII|Company Future Sales Volume GANX (Gain Therapeutics, Inc.)|EUDA - Company Expected Sales Volume|Company Projected Revenue Basel Medical BMGL|CollPlant Biotechnologies (CLGN) - Company Expected Sales Volume|CUPR: Company Future Sales Volume|Company Future Sales Concord Medical Services CCM|AMS (American Shared Hospital) - Company Future Sales Volume|Company Revenue Forecast MRM|Company Projected Revenue avalon-globocare.com|Projected Sales Volume DIH Holding US Inc.|Company Projected Revenue Carmell Therapeutics (XAGE)|newgenivf.com - Company Revenue Forecast|Company Projected Revenue ATI Physical Therapy Inc. ATIP|CMAX: Company Revenue Forecast|kindlymd.com - Projected Sales Volume|Company Expected Sales Volume ModivCare Corp|NVOS (Novo Integrated Sciences) - Company Future Sales Volume|SunLink Health Systems Inc. - Company Future Revenue|Company Future Sales Volume BACK